Read + Share
Amedeo Smart
Independent Medical Education
Velicki L, Popovic D, Okwose NC, Preveden A, et al. Sacubitril/valsartan for the treatment of non-obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM). Eur J Heart Fail 2024;26:1361-1368.PMID: 38800948
Email
LinkedIn
Privacy Policy